References
- Kerbel RS : Tumor angiogenesis: past, present and the nearfuture. Carcinogenesis 21: 505-515, 2000 https://doi.org/10.1093/carcin/21.3.505
- Ferrara N, Henzel WJ : Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858, 1989 https://doi.org/10.1016/0006-291X(89)92678-8
- Maglione D, Guerriero V, Viglietto G : Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271, 1991 https://doi.org/10.1073/pnas.88.20.9267
- Maglione D, Guerriero V, Viglietto G : Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8:925-931, 1993
- Olofsson B, Pajusola K, Kaipainen A, : Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93:2576-2581, 1996 https://doi.org/10.1073/pnas.93.6.2576
- Joukov V, Pajusola K, Kaipainen A : A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4(VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:1751-1758, 1996
- Lee J, Gray A, Yuan J, Luoh SM : Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93:1988-1992, 1996 https://doi.org/10.1073/pnas.93.5.1988
- Orlandini M, Marconcini L, Ferruzzi R : Identification of a c-fos-induced gene that is related to the plateletderived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93:11675-11680, 1996 https://doi.org/10.1073/pnas.93.21.11675
- Senger DR, Galli SJ, Dvorak AM : Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985, 1983 https://doi.org/10.1126/science.6823562
- Dvorak HF, Brown LF, Detmar M: Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039, 1995
- Benjamin LE, Golijanin D, Itin A : Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103: 159-165, 1999 https://doi.org/10.1172/JCI5028
- Yancopoulos GD, Davis S, Gale NW : Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000 https://doi.org/10.1038/35025215
- Jain RK : Molecular regulation of vessel maturation. Nat Med 9: 685-693, 2003 https://doi.org/10.1038/nm0603-685
- Ferrara N : Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 9 (Suppl 1): 2-10, 2004 https://doi.org/10.1634/theoncologist.9-suppl_1-2
- Fontanini G, Vignati S, Boldrini L : Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 3: 861-865, 1997
- Plouet J, Moukadiri HJ : Characterization of the receptors for vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J Biol Chem 265:22071-22075, 1990
- Vaisman N, Gospodarowicz D, Neufeld G : Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 265:19461-19466, 1990
- Jakeman LB, Winer J, Bennett GL, Altar CA : Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253, 1992 https://doi.org/10.1172/JCI115568
- Jakeman LB, Armanini M, Philips HS : Developmental expression of binding sites and mRNA for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133:848-859, 1993 https://doi.org/10.1210/en.133.2.848
- Shen H, Clauss M, Ryan J : Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81:2767-2773, 1993
- Shibuya M, Yamaguchi S, Yamane A : Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Oncogene 8:519-527, 1990
- Matthews W, Jordan CT, Gavin M : A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88:9026-9030, 1991 https://doi.org/10.1073/pnas.88.20.9026
- Terman BI, Carrion ME, Kovacs E : Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:1677-1683, 1991
- Ruzinova MB, Schoer RA, Gerald W : Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4:277-289, 2003 https://doi.org/10.1016/S1535-6108(03)00240-X
- Ferrara N and Davis-Smyth T : The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997 https://doi.org/10.1210/er.18.1.4
- Presta LG, Chen H, O'Connor S1 : Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57: 4593- 4599, 1997
- Kim KJ, Li B, Houck K, Winer J : The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutra lizing monoclonal antibodies. Growth Factors 7: 53-64, 1992 https://doi.org/10.3109/08977199209023937
- Gridelli C, Rossi A and Maione P : New antiangiogenetic agents and non-small cell lung cancer. Crit Rev Oncol Hematol 60: 76-86, 2006 https://doi.org/10.1016/j.critrevonc.2006.01.008
- Hurwitz H, Fehrenbacher L, Novotny W : Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342, 2004 https://doi.org/10.1056/NEJMoa032691
- Kabbinavar F, Hambleton I, Mass RD : Combined analysis of efficacy; the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23: 3706-3712, 2005 https://doi.org/10.1200/JCO.2005.00.232
- Iohnson DH, Fehrenbacher L, Novotny WF : Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small cell lung cancer. J Clin Onco1 22: 2184-2191, 2004 https://doi.org/10.1200/JCO.2004.11.022
- Cobleigh MA, Langmuir VK, Sledge GW : A phase I/Il dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol 30: 117-124, 2003 https://doi.org/10.1053/j.seminoncol.2003.08.013
- Borgstrom P, Bourdon MA and Ferrara N : Neutralizing anti-vascular endothelial growth factor, antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 35: 1-10 1998 https://doi.org/10.1002/(SICI)1097-0045(19980401)35:1<1::AID-PROS1>3.0.CO;2-O
- Berse B, Brown LF, and Senger DR : Vascular permeability factor(vasclar endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol BioI Cell 3: 211-220, 1992 https://doi.org/10.1091/mbc.3.2.211
- Folkman J, Merler E, Abernathy C : Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133:275-288, 1971 https://doi.org/10.1084/jem.133.2.275
- Folkman J and Klagsbrun M : Angiogenic factors. Science 235:442-447, 1987 https://doi.org/10.1126/science.2432664
- Gospodarowicz D, Ferrara N, Schweigerer L : Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8:95-114, 1987 https://doi.org/10.1210/edrv-8-2-95
- Thomas KA, Rios-Candelore M, Gimenez-Gallego G : Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci USA 82:6409-6413, 1985 https://doi.org/10.1073/pnas.82.19.6409
- Esch F, Baird A, Ling N : Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 82:6507-6511, 1985 https://doi.org/10.1073/pnas.82.19.6507
- Jaye M, Howk R, Burgess W : Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science 233:541-545, 1986 https://doi.org/10.1126/science.3523756
- Abraham JA, Mergia A, Whang JL : Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233:545-548, 1986 https://doi.org/10.1126/science.2425435
- Gospodarowicz D and Thakral KK : Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. Proc Natl Acad Sci USA 75:847-851, 1978 https://doi.org/10.1073/pnas.75.2.847
- Vlodavsky I, Folkman J, Sullivan R : Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84:2292-2296, 1987 https://doi.org/10.1073/pnas.84.8.2292
- Matsuzaki K, Yoshitake Y, Matuo Y : Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 86:9911- 9915, 1989 https://doi.org/10.1073/pnas.86.24.9911
- Dennis PA and Rifkin DB : Studies on the role of basic fibroblast growth factor in vivo: inability of neutralizing antibodies to block tumor growth. J Cell Physiol 144:84-98, 1990 https://doi.org/10.1002/jcp.1041440112
- Houck KA, Ferrara N, Winer J : The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814, 1991 https://doi.org/10.1210/mend-5-12-1806
- Tischer E, Mitchell R, Hartman T : The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954, 1991
- Tournier C, Hess P, Yang DD : Requirement of JNK for stressinduced activation of the cytochrome c-mediated death pathway. Science. 288: 870-874, 2000 https://doi.org/10.1126/science.288.5467.870
- Rajesh V, David S, Jeffery D : Expression of vascular endothelial growth factor receptors on tumor cells in head and neck aquamous cell carcinoma Arch Otolaryn Head Neck Surg 129; 882-888, 2003 https://doi.org/10.1001/archotol.129.8.882
- Volm M, Koomagi R, Mattern J : Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Res 17:99-103, 1997
- Volm M, Koomagi R and Mattern J : Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 74:64-68, 1997 https://doi.org/10.1002/(SICI)1097-0215(19970220)74:1<64::AID-IJC11>3.0.CO;2-I
- Brown LF, Berse B, Jackman RW : Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26:86-91, 1995 https://doi.org/10.1016/0046-8177(95)90119-1
- Brown LF, Berse B, Jackman RW : Expression of vascular permeability factor(vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727-4735, 1993
- Suzuki K, Hayashi N, Miyamoto Y : Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56:3004-3009, 1996
- Uchida S, Shimada Y, Watanabe G : In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer 77:1704-1709, 1998
- Brown LF, Berse B, Jackman RW : Increased expression of vascular permeability factor (vascular endothelial growth factor) and itsreceptors in kidney and bladder carcinomas. Am J Pathol 143:1255-1262, 1993
- Sowter HM, Corps AN, Evans AL : Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab Invest 77:607-614, 1997
- Kim KJ, Li B, Winer J : Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993 https://doi.org/10.1038/362841a0
- Presta LG, Chen H, O'Connor SJ : Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57:4593- 4599, 1997
- Fong TA, Shawver LK, Sun L : SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 59: 99-106, 1999
- Wedge SR, Ogilvie DJ, Dukes M : ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy. Cancer Res 60: 970-975, 2000
- D. Sano, M Kawakami, K Fujita : Antitumor effect of ZD6474 on head and neck squamous cell carcinoma. Oncology Reports 17; 289-295, 2007